News Releases

Nextrials Named to Inc. 5000 for Fourth Consecutive Year

Nextrials selected as one of the fastest growing companies in the U.S. despite slow national economic growth

SAN RAMON, Calif., Aug. 25 /PRNewswire/ -- Nextrials, Inc. (, a leader in clinical research software and services, today announced that the company has been selected for the fourth consecutive year for the prestigious Inc. 5000, an exclusive list of the fastest growing private companies in the U.S. Despite the challenging financial economics within the pharmaceutical industry in 2009, Nextrials maintained its position on the Inc. 5000 and achieved the national ranking of No. 2,678, based on the company's year over year revenue growth for the past three years.



"During the past year, Nextrials again proved itself to be at the forefront by completing the industry's first multi-site pilot study using an integrated electronic data capture (EDC) and electronic health records (EHR) platform," noted James Rogers, co-founder and CEO of Nextrials. "In 2009, we significantly upgraded Prism™, our clinical trial management platform, with ad hoc reporting capabilities and a more intuitive user interface. We also gained certification for compliance with the federally recognized Healthcare Information Technology Standards Panel 's (HITSP) interoperability specifications. And we achieved all of this while upholding Nextrials' reputation as an organization that delivers the highest level of customer service."

The Inc. 5000 is a comprehensive look at American entrepreneurs. To be considered, companies must be U.S.-based and privately held, for profit and independent – not subsidiaries or divisions of other companies. The 5000 companies that made the list reported aggregate revenue of $321.6 billion and median three-year growth of 96 percent, down from last year's 126 percent. Complete results of the Inc. 5000, including company profiles and a list of the fastest-growing companies that can be sorted by industry and region can be found at

About Nextrials

Founded by pharmaceutical researchers in 1999, Nextrials offers today's most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism™, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,500 research sites to streamline the initiation and management of clinical trials.  The company is headquartered in the San Francisco Bay area. For more information, visit or call 925-355-3000.

SOURCE Nextrials, Inc.

For further information: Rachel V. Berry of VOXUS, Inc., +1-253-444-5441, for Nextrials, Inc.